Investors

Biostage has created a product that leading surgeons describe as, “revolutionary, “a breakthrough in tissue engineering and regenerative medicine” and that “would have considerable clinical use”.  - all quotes by top surgeons, from Massachusetts General Hospital, Mayo Clinic and Connecticut Children’s Medical Center.

Stock Information
OTCQBBSTG
Press Releases
Jun 15, 2022

The current study tested the biomechanical strength of the newly regenerated esophageal tissue and demonstrated that the strength of the tissue was comparable to adjacent native tissue. HOLLISTON,...

May 16, 2022

Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful "first-in-human" experience in treating esophageal cancer (conducted at the Mayo...

May 13, 2022

Biostage, Inc. (OTCQB: BSTG) ("Biostage" or the "Company"), a cell-therapy biotechnology company with successful first-in-human experience in treating esophageal cancer (conducted at the Mayo...

More >

Contact Us

Biostage, Inc.
84 October Hill Road
Suite 11
Holliston, Massachusetts 01746
United States

Phone: 774-233-7300
Toll Free: 855-209-3104
Fax: 774-233-7302

Investor Presentation

  
Download PDF

Fact Sheet